Jump to content

Autoimmune disease

Shí Wikipedia, njikotá édémédé nke onyobulạ
Autoimmune disease
class of disease
obere ụdị nkehypersensitivity, disease, immune disorder, primary immunodeficiency disease Dezie
ihe kpatara yatype II hypersensitivity Dezie
nwere mmetụtanodding disease, systemic lupus erythematosus, rheumatoid arthritis Dezie
afflictsimmune system Dezie
health specialtyimmunology, rheumatology Dezie
drug or therapy used for treatmentcyclosporine, azathioprine, dexamethasone, prednisone, methylprednisolone Dezie
manifestation ofautoimmunity Dezie
ICD-9-CM720 Dezie
NCI Thesaurus IDC2889 Dezie

Ọrịa autoimmune bụ ọnọdụ na-esite na nzaghachi mgbochi na-adịghị mma na akụkụ ahụ na-arụ ọrụ [1] E nwere ma ọ dịkarịa ala ụdị ọrịa iri asatọ na-alụso ọrịa ọgụ. Ihe fọrọ nke nta [2] ọ bụrụ akụkụ ahụ ọ bụla nwere ike itinye aka. Mgb[1] ndị a na-ahụkarị gụnyere oke ọkụ na ike ọgwụgwụ. Ọtụtụ mgbe mgbaàmà na-abịa ma na-aga. [1]

[2] Amaghị ihe na akpata ya. Ụfọdụ ọrịa autoimmune [1] ka lupus na-agba ọsọ n'ezinụlọ, na ụfọdụ ikpe nwere ike ibute ọrịa ma ọ bụ ihe ndị ọzọ metụtara gburugburu ebe obibi. Ụfọdụ ọrịa ndị a na-ahụkarị nke a na-ewere n'ozuzu ha dị ka ọrịa na-alụso ọrịa ọgụ gụnyere Ọrịa celiac, ọrịa shuga, Ọrịa Graves, Ọrịa eriri afọ, ọrịa multiple sclerosis, psoriasis, rheumatoid arthritis, na systemic lupus erythematosus.[1][3] [1] nwere ike isi ike ịchọpụta nchọpụta ahụ.

Ọgwụgwọ -adabere na ụdị na ịdị njọ nke ọnọdụ ahụ.. [1] na-ejikarị ọgwụ nonsteroidal anti-inflammatory (NSAIDs) na immunosuppressants eme ihe. [4] pụkwara iji immunoglobulin intravenous mee ihe mgbe ụfọdụ. [1] bụ ezie na ọgwụgwọ na-emekarị ka mgbaàmà dị mma, ha anaghị agwọ ọrịa ahụ.

Ihe dịka ka nde mmadụ iri abụọ na anọ (7%) na United States nwere ọrịa autoimmune[2] [1]Ụmụ nwanyị ka ọ na emetụtakarị karịa ụmụ nwoke. [1] na-amalite mgbe ha toro. [5] kọwara ọrịa mbụ nke autoimmune na mbido afọ 1900.

Edensibia

[dezie | dezie ebe o si]
  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 Autoimmune diseases fact sheet. Office on Women's Health. U.S. Department of Health and Human Services (16 July 2012). Archived from the original on 5 October 2016. Retrieved on 5 October 2016.
  2. 2.0 2.1 2.2 Borgelt (2010). Women's Health Across the Lifespan: A Pharmacotherapeutic Approach (in en). ASHP. ISBN 978-1-58528-194-7. 
  3. (February 2016) "The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets". The Lancet. Neurology 15 (2): 198–209. DOI:10.1016/S1474-4422(15)00334-8. PMID 26724103. 
  4. (2011) "Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases". Current Pharmaceutical Design 17 (29): 3166–75. DOI:10.2174/138161211798157540. PMID 21864262. 
  5. (2005) Ananthanarayan and Paniker's Textbook of Microbiology (in en). Orient Blackswan. ISBN 9788125028086.